Bendroflumetiazide [Dcit] en es it fr

Bendroflumetiazide [Dcit] Brand names, Bendroflumetiazide [Dcit] Analogs

Bendroflumetiazide [Dcit] Brand Names Mixture

  • Corzide Tab W Nadolol 40mg (Bendroflumethiazide + Nadolol)
  • Corzide Tab W Nadolol 80mg (Bendroflumethiazide + Nadolol)

Bendroflumetiazide [Dcit] Chemical_Formula

C15H14F3N3O4S2

Bendroflumetiazide [Dcit] RX_link

No information avaliable

Bendroflumetiazide [Dcit] fda sheet

Bendroflumetiazide [Dcit] msds (material safety sheet)

Bendroflumetiazide [Dcit] Synthesis Reference

No information avaliable

Bendroflumetiazide [Dcit] Molecular Weight

421.417 g/mol

Bendroflumetiazide [Dcit] Melting Point

221-223 oC

Bendroflumetiazide [Dcit] H2O Solubility

108 mg/L

Bendroflumetiazide [Dcit] State

Solid

Bendroflumetiazide [Dcit] LogP

2.085

Bendroflumetiazide [Dcit] Dosage Forms

Tablet

Bendroflumetiazide [Dcit] Indication

For the treatment of high blood pressure and management of edema

Bendroflumetiazide [Dcit] Pharmacology

Bendroflumethiazide, a thiazide diuretic, removes excess water from the body by increasing how often you urinate (pass water) and also widens the blood vessels which helps to reduce blood pressure. It inhibits Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.

Bendroflumetiazide [Dcit] Absorption

Absorbed relatively rapidly after oral administration

Bendroflumetiazide [Dcit] side effects and Toxicity

No information avaliable

Bendroflumetiazide [Dcit] Patient Information

No information avaliable

Bendroflumetiazide [Dcit] Organisms Affected

Humans and other mammals